Search all trials

Find therapies in clinical trials near you – page 9

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Cytomegalovirus infection

Recruiting

Registered drugNo placebo

Study on Valacyclovir for Preventing and Treating Cytomegalovirus (CMV) in Pregnant Women

Registered drugNo placebo

Poland

Participants:18–64 years
Substances:Valaciclovir

Contact Research Centre

Non-small cell lung cancer metastatic

Recruiting

Registered drugNo placebo

Study Comparing MK-2870 and Pembrolizumab Combination to Pembrolizumab Alone for Patients with Metastatic Non-Small Cell Lung Cancer with High PD-L1 Levels

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Acetylsalicylic Acid

Contact Research Centre

Non-small cell lung cancer

Recruiting

Registered drug

Study of V940 and Pembrolizumab for Patients with Resected Stage II, IIIA, IIIB Non-Small Cell Lung Cancer

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Mrna-4157

Contact Research Centre

Non-Hodgkin's lymphoma

Recruiting

Registered drugNo placebo

Study on Lymphoblastic Lymphoma Treatment in Children and Adolescents Using Dexamethasone, Prednisone, and PEG-Asparaginase

Registered drugNo placebo

Poland

Participants:0–17 years
Substances:Cyclophosphamide

Contact Research Centre

Neoplasm+5

Recruiting

Registered drugNo placebo

Study for Patients with Lung or Urinary Tract Cancer Continuing Treatment with Durvalumab, Infliximab, and Mycophenolate Mofetil

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Durvalumab

Contact Research Centre

Acute myeloid leukaemia

Recruiting

Registered drug

Study on Personalized Treatment for Acute Myeloid Leukemia Using Cladribine, Daunorubicin, Cytarabine, and Drug Combinations for Specific Patient Groups

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Cladribine

Contact Research Centre

Non-small cell lung cancer+1

Recruiting

Registered drugNo placebo

Study on the Safety and Effects of Divarasib with Pembrolizumab and a Drug Combination for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer with KRAS G12C Mutation

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Budesonide

Contact Research Centre

Non-small cell lung cancer

Recruiting

Registered drug

Study of MK-1084 and Pembrolizumab for First-Line Treatment in Patients with Metastatic Non-Small Cell Lung Cancer with KRAS G12C Mutation and High PD-L1 Levels

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Mk-1084

Contact Research Centre

Chronic lymphocytic leukaemia+1

Recruiting

Registered drugNo placebo

Study Comparing Nemtabrutinib, Ibrutinib, and Acalabrutinib for Patients with Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Acalabrutinib

Contact Research Centre

Thalassaemia beta+2

Recruiting

InvestigationalNo placebo

Study of SP-420 for Patients with Transfusion-Dependent Alpha or Beta Thalassemia

InvestigationalNo placebo

Poland

Participants:18–64 years
Substances:(S)-4,5-Dihydro-2-[2-Hydroxy-4-(3,6-Dioxaheptyloxy)Phenyl]-4-Methyl-4-Thiazolecarboxylic Acid

Contact Research Centre

Cardiac failure

Recruiting

Registered drug

Study on Balcinrenone and Dapagliflozin for Patients with Heart Failure and Kidney Problems

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Balcinrenone

Contact Research Centre

Non-small cell lung cancer

Recruiting

Registered drugNo placebo

Study to Compare Datopotamab Deruxtecan with Rilvegostomig or Alone Against Pembrolizumab in Patients with Advanced Non-Small Cell Lung Cancer with High PD-L1 Levels

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Infliximab

Contact Research Centre

Find therapies in clinical trials near you – page 9

300 trials match your criteria

Cytomegalovirus infection

Study on Valacyclovir for Preventing and Treating Cytomegalovirus (CMV) in Pregnant Women

Non-small cell lung cancer metastatic

Study Comparing MK-2870 and Pembrolizumab Combination to Pembrolizumab Alone for Patients with Metastatic Non-Small Cell Lung Cancer with High PD-L1 Levels

Non-small cell lung cancer

Study of V940 and Pembrolizumab for Patients with Resected Stage II, IIIA, IIIB Non-Small Cell Lung Cancer

Non-Hodgkin's lymphoma

Study on Lymphoblastic Lymphoma Treatment in Children and Adolescents Using Dexamethasone, Prednisone, and PEG-Asparaginase

Neoplasm+5

Study for Patients with Lung or Urinary Tract Cancer Continuing Treatment with Durvalumab, Infliximab, and Mycophenolate Mofetil

Acute myeloid leukaemia

Study on Personalized Treatment for Acute Myeloid Leukemia Using Cladribine, Daunorubicin, Cytarabine, and Drug Combinations for Specific Patient Groups

Non-small cell lung cancer+1

Study on the Safety and Effects of Divarasib with Pembrolizumab and a Drug Combination for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer with KRAS G12C Mutation

Non-small cell lung cancer

Study of MK-1084 and Pembrolizumab for First-Line Treatment in Patients with Metastatic Non-Small Cell Lung Cancer with KRAS G12C Mutation and High PD-L1 Levels

Chronic lymphocytic leukaemia+1

Study Comparing Nemtabrutinib, Ibrutinib, and Acalabrutinib for Patients with Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Thalassaemia beta+2

Study of SP-420 for Patients with Transfusion-Dependent Alpha or Beta Thalassemia

Cardiac failure

Study on Balcinrenone and Dapagliflozin for Patients with Heart Failure and Kidney Problems

Non-small cell lung cancer

Study to Compare Datopotamab Deruxtecan with Rilvegostomig or Alone Against Pembrolizumab in Patients with Advanced Non-Small Cell Lung Cancer with High PD-L1 Levels

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.